Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 2,982 $ 1,760
Premium and related receivables 3,445 1,279
Short term investments 406 176
Other current assets 922 390
Total current assets 7,755 3,605
Long term investments 4,568 1,927
Restricted deposits 137 115
Property, software and equipment, net 725 518
Goodwill 4,730 842
Intangible assets, net 1,566 155
Other long term assets 153 177
Total assets 19,634 7,339
Current liabilities:    
Medical claims liability 3,767 2,298
Accounts payable and accrued expenses 3,187 976
Return of premium payable 651 207
Unearned revenue 573 143
Current portion of long term debt 845 5
Total current liabilities 9,023 3,629
Long term debt 3,744 1,216
Other long term liabilities 995 170
Total liabilities 13,762 5,015
Commitments and contingencies
Redeemable noncontrolling interests 148 156
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at September 30, 2016 and December 31, 2015 0 0
Common stock, $0.001 par value; authorized 400,000,000 shares; 176,467,825 issued and 170,860,752 outstanding at September 30, 2016, and 126,855,477 issued and 120,342,981 outstanding at December 31, 2015 0 0
Additional paid-in capital 4,154 956
Accumulated other comprehensive earnings (loss) 46 (10)
Retained earnings 1,655 1,358
Treasury stock, at cost (5,607,073 and 6,512,496 shares, respectively) (145) (147)
Total Centene stockholders’ equity 5,710 2,157
Noncontrolling interest 14 11
Total stockholders’ equity 5,724 2,168
Total liabilities and stockholders’ equity $ 19,634 $ 7,339